155 related articles for article (PubMed ID: 30593674)
21. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
[TBL] [Abstract][Full Text] [Related]
22. Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.
Kimmel SE; French B; Anderson JL; Gage BF; Johnson JA; Rosenberg YD; Geller NL; Kasner SE; Eby CS; Joo J; Caldwell MD; Goldhaber SZ; Hart RG; Cifelli D; Madigan R; Brensinger CM; Goldberg S; Califf RM; Ellenberg JH
Am Heart J; 2013 Sep; 166(3):435-41. PubMed ID: 24016491
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
Kasner SE; Wang L; French B; Messe SR; Horenstein R; Mohler ER; Muldowney JA; Ellenberg J; Kimmel SE
Am J Cardiovasc Drugs; 2015 Aug; 15(4):267-74. PubMed ID: 26037731
[TBL] [Abstract][Full Text] [Related]
24. Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.
Guo C; Kuang Y; Zhou H; Yuan H; Pei Q; Li J; Jiang W; Ng CM; Chen X; Huo Y; Cui Y; Wang X; Yu J; Sun X; Yu W; Chen P; Miao D; Liu W; Yu Z; Ouyang Z; Shi X; Lv C; Peng Z; Xiong G; Zeng G; Zeng J; Dai H; Peng J; Zhang Y; Xu F; Wu J; Chen X; Gong H; Yang Z; Wu X; Fang Q; Yang L; Li H; Tan H; Huang Z; Tang X; Yang Q; Tu S; Wang X; Xiang Y; Huang J; Wang X; Cai J; Jiang S; Huang L; Peng J; Gong L; Zou C; Yang G
Circ Genom Precis Med; 2020 Aug; 13(4):e002602. PubMed ID: 32510984
[TBL] [Abstract][Full Text] [Related]
25. Vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
[TBL] [Abstract][Full Text] [Related]
26. Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
Syn NL; Wong AL; Lee SC; Teoh HL; Yip JWL; Seet RC; Yeo WT; Kristanto W; Bee PC; Poon LM; Marban P; Wu TS; Winther MD; Brunham LR; Soong R; Tai BC; Goh BC
BMC Med; 2018 Jul; 16(1):104. PubMed ID: 29986700
[TBL] [Abstract][Full Text] [Related]
27. Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation. A systematic review and meta-analysis.
Belley-Cote EP; Hanif H; D'Aragon F; Eikelboom JW; Anderson JL; Borgman M; Jonas DE; Kimmel SE; Manolopoulos VG; Baranova E; Maitland-van der Zee AH; Pirmohamed M; Whitlock RP
Thromb Haemost; 2015 Oct; 114(4):768-77. PubMed ID: 26158747
[TBL] [Abstract][Full Text] [Related]
28. Optimal loading dose of warfarin for the initiation of oral anticoagulation.
Mahtani KR; Heneghan CJ; Nunan D; Bankhead C; Keeling D; Ward AM; Harrison SE; Roberts NW; Hobbs FD; Perera R
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD008685. PubMed ID: 23235665
[TBL] [Abstract][Full Text] [Related]
29. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
30. Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
Shendre A; Brown TM; Liu N; Hill CE; Beasley TM; Nickerson DA; Limdi NA
Pharmacotherapy; 2016 Mar; 36(3):263-72. PubMed ID: 26877068
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Verhoef TI; Ragia G; de Boer A; Barallon R; Kolovou G; Kolovou V; Konstantinides S; Le Cessie S; Maltezos E; van der Meer FJ; Redekop WK; Remkes M; Rosendaal FR; van Schie RM; Tavridou A; Tziakas D; Wadelius M; Manolopoulos VG; Maitland-van der Zee AH;
N Engl J Med; 2013 Dec; 369(24):2304-12. PubMed ID: 24251360
[TBL] [Abstract][Full Text] [Related]
32. Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.
Xu Z; Zhang SY; Huang M; Hu R; Li JL; Cen HJ; Wang ZP; Ou JS; Yin SL; Xu YQ; Wu ZK; Zhang X
Ann Thorac Surg; 2018 Dec; 106(6):1774-1781. PubMed ID: 30205115
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation.
Patrick AR; Avorn J; Choudhry NK
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):429-36. PubMed ID: 20031873
[TBL] [Abstract][Full Text] [Related]
34. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Anderson JL; Horne BD; Stevens SM; Woller SC; Samuelson KM; Mansfield JW; Robinson M; Barton S; Brunisholz K; Mower CP; Huntinghouse JA; Rollo JS; Siler D; Bair TL; Knight S; Muhlestein JB; Carlquist JF
Circulation; 2012 Apr; 125(16):1997-2005. PubMed ID: 22431865
[TBL] [Abstract][Full Text] [Related]
35. Oral anticoagulation for prolonging survival in patients with cancer.
Akl EA; Kamath G; Kim SY; Yosuico V; Barba M; Terrenato I; Sperati F; Schünemann HJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD006466. PubMed ID: 17443622
[TBL] [Abstract][Full Text] [Related]
36. Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
Carmo J; Ferreira J; Costa F; Carmo P; Cavaco D; Carvalho S; Morgado F; Adragão P; Mendes M
Int J Cardiol; 2017 Oct; 244():196-201. PubMed ID: 28679480
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomics and warfarin therapy.
Ndegwa S
Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
[No Abstract] [Full Text] [Related]
39. Genetic testing for warfarin therapy initiation.
Hynicka LM; Cahoon WD; Bukaveckas BL
Ann Pharmacother; 2008 Sep; 42(9):1298-303. PubMed ID: 18682545
[TBL] [Abstract][Full Text] [Related]
40. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2013 Jun; 35(3):359-68. PubMed ID: 21052837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
